BioVersys AG (SWX:BIOV)
Switzerland · Delayed Price · Currency is CHF 24.00
-0.10 (-0.41%)
At close: Jan 30, 2026
BioVersys AG Market Cap
BioVersys AG has a market cap or net worth of 140.35 million as of January 30, 2026.
Market Cap
140.35M
Enterprise Value
66.53M
Revenue
1.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
24.00
Market Cap Chart
Since February 6, 2025, BioVersys AG's market cap has decreased from 207.92M to 140.35M, a decrease of -32.50%. That is a compound annual growth rate of -33.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 140.35M | -1.64% |
| Dec 30, 2025 | 142.69M | -31.37% |
| Feb 6, 2025 | 207.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Idorsia | 916.44M |
| Basilea Pharmaceutica AG | 663.56M |
| Newron Pharmaceuticals | 389.88M |
| Santhera Pharmaceuticals Holding AG | 175.98M |
| Xlife Sciences AG | 127.46M |
| Molecular Partners AG | 120.61M |
| EvoNext Holdings | 6.20M |
| Addex Therapeutics | 5.83M |